COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 608: Articles 6071-6080  | Next

Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
Uraki, R., Iida, S., Halfmann, P. J., Yamayoshi, S., Hirata, Y., Iwatsuki-Horimoto, K., Kiso, M., Ito, M., Furusawa, Y., Ueki, H., Sakai-Tagawa, Y., Kuroda, M., Maemura, T., Kim, T., Mine, S., Kinoshita-Iwamoto, N., Li, R., Liu, Y., Larson, D., Fukushi, S., Watanabe, S., Maeda, K., Wang, Z., Ohmagari, N., Theiler, J., Fischer, W., Korber, B., Imai, M., Suzuki, T., Kawaoka, Y.
10.1101/2022.08.26.505450 — Posted: 2022-08-26
Enhancer deregulation in TET2 Mutant Clonal Hematopoiesis is associated with increased COVID-19 related inflammation severity and mortality
Binder, M., Lasho, T. L., Ismail, W. M., Ben-Crentsil, N. A., Fernandez, J. A., Kim, M., Geyer, S. M., Mazzone, A., Finke, C. M., Mangaonkar, A. A., Lee, J.-H., Hyun Kim, K., Simon, V. A., Rohakthar, F. R., Munankarmy, A., Schwager, S. M., Harrington, J. J., Snyder, M. R., Droin, N. M., Solary, E., Robertson, K. D., Wieben, E. D., Padron, E., Chia, N., Gaspar-Maia, A., Patnaik, M. M.
10.1101/2022.08.25.505316 — Posted: 2022-08-26
Predicting the efficacy of variant-modified COVID-19 vaccine boosters
Khoury, D. S., Docken, S. S., Subbarao, K., Kent, S., Davenport, M. P., Cromer, D.
10.1101/2022.08.25.22279237 — Posted: 2022-08-26
Evaluation of Secondary Chemistry due to Disinfection of Indoor Air with Germicidal Ultraviolet Lamps
Peng, Z., Jimenez, J. L.
10.1101/2022.08.25.22279238 — Posted: 2022-08-26
A survey of patient and public perceptions and awareness of SARS-CoV-2-related risks among participants in India and South Africa
Mbamalu, O. N., Surendran, S., Nampoothiri, V., Bonaconsa, C., Edathadathil, F., Zhu, N., Carter, V., Lambert, H., Tarrant, C., Ahmad, R., Brink, A., Steenkamp, E., Holmes, A., Singh, S., Charani, E., Mendelson, M.
10.1101/2022.08.26.22279242 — Posted: 2022-08-26
International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship
Raad, I., Hachem, R., Nigo, M., Datoguia, T., Dagher, H., Jiang, Y., Subbiah, V., Siddiqui, B., Bayle, A., Somer, R., Fernandez-Cruz, A., Gorak, E., Bhinder, A., Nobuyoshi, M., Hamerschlak, N., Shelanski, S., Dragovich, T., Kiat, Y. E. V., Fakhreddine, S., Hanna, P. A., Chemaly, R. F., Mulanovich, V., Adachi, J. A., Borjan, J., Khawaja, F., Granwehr, B., John, T., Guevara, E. Y., Torres, H., Ammakkanavar, N. R., Yibirin, M., Reyes, C., Pande, M., Ali, N., Rojo, R., Ali, S., Deeba, R., Chaftari, P., Matsuo, T., Ishikawa, K., Hasegawa, R., Aguado-Noya, R., Garcia, A. G., Puchol, C. T., Lee, D.-G., Slavin, M., Teh, B. W., Arias, C. A., Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, , Kontoyiannis, D., Malek, A. E., Chaftari, A. M.
10.1101/2022.08.25.22279181 — Posted: 2022-08-26
Homologous and heterologous boosting with CoronaVac and BNT162b2: a randomized trial (the Cobovax study)
Leung, N. H. L., Cheng, S. M. S., Cohen, C. A., Martin-Sanchez, M., Au, N. Y. M., Luk, L. L. H., Tsang, L. C. H., Kwan, K. K. H., Chaothai, S., Fung, L. W. C., Cheung, A. W. L., Chan, K. C. K., Li, J. K. C., Ng, Y. Y., Kaewpreedee, P., Jia, J. Z., Ip, D. K. M., Poon, L. L. M., Leung, G. M., Peiris, M., Valkenburg, S. A., Cowling, B. J.
10.1101/2022.08.25.22279158 — Posted: 2022-08-26
Use of whole genome sequencing to estimate the contribution of immune evasion and waning immunity to decreasing COVID-19 vaccine effectiveness during alpha and delta variant waves
Lind, M., Copin, R., McCarthy, S., Coppi, A., Warner, F., Ferguson, D., Duckwall, C., Borg, R., Muenker, M. C., Overton, J., Hamon, S., Zhou, A., Cummings, D. A. T., Ko, A., Hamilton, J., Schulz, W. L., Hitchings, M.
10.1101/2022.08.25.22278443 — Posted: 2022-08-26
Susceptibility and infectiousness of SARS-CoV-2 in children versus adults, by variant (wild-type, Alpha, Delta): a systematic review and meta-analysis of household contact studies
Uthman, O., Lyngse, F., Anjorin, S., Hauer, B., Hakki, S., Martinez, D., Ge, Y., Jonnerby, J., Julin, C., Lin, G., Lalvani, A., Loss, J., Madon, K., Martinez, L., Naess, L., Page, K., Prieto, D., Robertson, A., Shen, Y., Wurm, J., Buchholz, U.
10.1101/2022.08.26.22279248 — Posted: 2022-08-26
Mortality Improvements in Adult Patients Hospitalised with Community Acquired COVID-19 in Wales From March 2020 to Decemeber 2021
Barry, S. M., Davies, G. R., Davies, C. R., Lewis, K. E.
10.1101/2022.08.26.22279219 — Posted: 2022-08-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).